Coverart for item
The Resource Prostate cancer : signaling networks, genetics, and new treatment strategies, edited by Richard G. Pestell, Marja T. Nevalainen ; foreword by Michael Milken, (electronic book)

Prostate cancer : signaling networks, genetics, and new treatment strategies, edited by Richard G. Pestell, Marja T. Nevalainen ; foreword by Michael Milken, (electronic book)

Label
Prostate cancer : signaling networks, genetics, and new treatment strategies
Title
Prostate cancer
Title remainder
signaling networks, genetics, and new treatment strategies
Statement of responsibility
edited by Richard G. Pestell, Marja T. Nevalainen ; foreword by Michael Milken
Contributor
Subject
Language
eng
Member of
Cataloging source
GW5XE
Dewey number
616.99463
Illustrations
illustrations
Index
index present
LC call number
RC280.P7
LC item number
P75992 2008eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Pestell, Richard G
  • Nevalainen, Marja T
Series statement
Current clinical oncology
http://library.link/vocab/subjectName
  • Prostate
  • Prostate
  • Prostate
  • Cellular signal transduction
  • Prostatic Neoplasms
Label
Prostate cancer : signaling networks, genetics, and new treatment strategies, edited by Richard G. Pestell, Marja T. Nevalainen ; foreword by Michael Milken, (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
Histopathology and molecular biology of prostate atrophy: a lesion associated with inflammation, prostate intraepithelial neoplasia, and prostate cancer -- Epigenetic gene silencing in prostate cancer -- Inherited genetic changes in prostate cancer -- Prostate molecular oncogenesis: gene deletions and somatic mutations -- Somatic genetic changes in prostate cancer: androgen receptor alterations -- Androgen receptor in prostate cancer progression -- Epigenetic modification and acetylation of androgen receptor regulate prostate cellular growth -- Estrogen receptor a [alpha] and b [beta] in the regulation of normal and malignant prostate epithelium -- Estrogen action in normal prostate epithelium and in prostate cancer -- Hypoxia-inducible factor 1 in the angiogenesis of prostate cancer -- Signal transduction by the Ras-MAP kinase pathway in prostate cancer progression -- Transcription factors STAT5 and STAT3: survival factors for prostate cancer cells -- Role of P13K-Akt and PTEN in the growth and progression of prostate cancer -- New perspectives in prediction of clinical outcome of prostate cancer; TMPRSS2-ETS gene fusion in prostate cancer -- New directions in radiation therapy of prostate cancer: brachytherapy and intensity-modulated radiation therapy -- The current knowledge of hormonal therapy in the treatment of prostate cancer -- Advances in surgical intervention of prostate cancer: comparison of the benefits and pitfalls of retropubic, perineal, and laparoscopic radical prostatectormy -- Targeted therapy trials for prostate cancer -- New perspectives on chemotherapy in prostate cancer -- Concluding remarks: the future of prostate cancer
Control code
SPR233972796
Dimensions
unknown
Extent
1 online resource (xv, 455 p.)
Form of item
online
Isbn
9781603270793
Other physical details
ill.
Specific material designation
remote
Label
Prostate cancer : signaling networks, genetics, and new treatment strategies, edited by Richard G. Pestell, Marja T. Nevalainen ; foreword by Michael Milken, (electronic book)
Publication
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
Histopathology and molecular biology of prostate atrophy: a lesion associated with inflammation, prostate intraepithelial neoplasia, and prostate cancer -- Epigenetic gene silencing in prostate cancer -- Inherited genetic changes in prostate cancer -- Prostate molecular oncogenesis: gene deletions and somatic mutations -- Somatic genetic changes in prostate cancer: androgen receptor alterations -- Androgen receptor in prostate cancer progression -- Epigenetic modification and acetylation of androgen receptor regulate prostate cellular growth -- Estrogen receptor a [alpha] and b [beta] in the regulation of normal and malignant prostate epithelium -- Estrogen action in normal prostate epithelium and in prostate cancer -- Hypoxia-inducible factor 1 in the angiogenesis of prostate cancer -- Signal transduction by the Ras-MAP kinase pathway in prostate cancer progression -- Transcription factors STAT5 and STAT3: survival factors for prostate cancer cells -- Role of P13K-Akt and PTEN in the growth and progression of prostate cancer -- New perspectives in prediction of clinical outcome of prostate cancer; TMPRSS2-ETS gene fusion in prostate cancer -- New directions in radiation therapy of prostate cancer: brachytherapy and intensity-modulated radiation therapy -- The current knowledge of hormonal therapy in the treatment of prostate cancer -- Advances in surgical intervention of prostate cancer: comparison of the benefits and pitfalls of retropubic, perineal, and laparoscopic radical prostatectormy -- Targeted therapy trials for prostate cancer -- New perspectives on chemotherapy in prostate cancer -- Concluding remarks: the future of prostate cancer
Control code
SPR233972796
Dimensions
unknown
Extent
1 online resource (xv, 455 p.)
Form of item
online
Isbn
9781603270793
Other physical details
ill.
Specific material designation
remote

Library Locations